Andrea Wolf, MD

Born in Brooklyn, NY, and raised in New Jersey, Dr. Wolf graduated Cum Laude from Princeton University and earned highest honors and her medical degree at Harvard Medical School. She trained in General Surgery and served as Chief Resident at Massachusetts General Hospital in Boston. Dr. Wolf earned a Master in Public Health with a focus on Clinical Effectiveness at Harvard University School of Public Health while researching malignant pleural mesothelioma and early stage lung cancer as a Thoracic Oncology Research Fellow at Brigham and Women’s Hospital, also in Boston. She completed her training in Cardiothoracic Surgery after serving as Chief Resident in Thoracic Surgery at Brigham and Women’s Hospital.

Dr. Wolf is Director of the New York Mesothelioma Program at the Mount Sinai Health System, which provides comprehensive, multidisciplinary clinical care for patients with suspected or diagnosed malignant pleural mesothelioma. She has expertise in surgery for pleural mesothelioma and VATS lobectomy, and research interests in mesothelioma, health care disparities, and lung cancer. Dr. Wolf and her team at the New York Mesothelioma Program received the 2020 International Association for the Study of Lung Cancer (IASLC) Cancer Care Team Award; Dr. Wolf  received the 2022 Asbestos Disease Awareness Organization Irving J. Selikoff Award. She has presented at numerous national and international meetings, is co-editor of the third edition of Sugarbaker’s Adult Chest Surgery, and has published extensively on pleural mesothelioma and lung cancer. 

Dr. Wolf specializes in General Thoracic Surgery and has expertise in robotic and minimally-invasive techniques, including video-assisted thoracic (VATS) and laparoscopic surgery for benign and malignant diseases of the chest wall, lung, mediastinum, diaphragm, and esophagus. She is certified by both the American Board of Thoracic Surgery and the American Board of Surgery. Dr. Wolf is fluent in Hebrew.